Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Sandostatin LAR Depot (octreotide)
- Signifor (pasireotide)
Interactions between your drugs
No drug ⬌ drug interactions were found between the drugs in your list. However, this does not necessarily mean no drug interactions exist. Always consult your healthcare provider.
Drug and food/lifestyle interactions
octreotide food/lifestyle
Applies to: Sandostatin LAR Depot (octreotide)
Octreotide may affect the absorption of dietary nutrients and medications that you take by mouth, including some vitamin and nutritional supplements. Contact your doctor if your condition changes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Growth hormone release inhibitors
Therapeutic duplication
The recommended maximum number of medicines in the 'growth hormone release inhibitors' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'growth hormone release inhibitors' category:
- Sandostatin LAR Depot (octreotide)
- Signifor (pasireotide)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Sandostatin
Sandostatin is used to treat acromegaly and to reduce flushing episodes and watery diarrhea caused ...
Mycapssa
Mycapssa (octreotide) is used for the treatment of acromegaly. Includes Mycapssa side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Bynfezia Pen
Bynfezia Pen (octreotide) is used to treat acromegaly and to reduce flushing episodes and watery ...
Signifor
Signifor (pasireotide) is a man-made protein that is similar to somatostatin and is used to treat ...
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Octreotide
Octreotide is used for acromegaly, carcinoid tumor, diabetes, type 1, diarrhea, dumping syndrome ...
Lanreotide
Lanreotide (Somatuline Depot) is an injectable medication containing a man-made (synthetic ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.